Dengue fever seroprevalence and risk factors, Texas-Mexico border, 2004

Joan Marie Brunkard, Jose Luis Robles López, Josue Ramirez, Enrique Cifuentes, Stephen J Rothenberg, Elizabeth A Hunsperger, Chester G Moore, Regina M Brussolo, Norma A Villarreal, Brent M Haddad, Joan Marie Brunkard, Jose Luis Robles López, Josue Ramirez, Enrique Cifuentes, Stephen J Rothenberg, Elizabeth A Hunsperger, Chester G Moore, Regina M Brussolo, Norma A Villarreal, Brent M Haddad

Abstract

Reported autochthonous dengue fever transmission in the United States has been limited to 5 south Texas border counties since 1980. We conducted a cross-sectional serosurvey in Brownsville, Texas, and Matamoros, Tamaulipas, Mexico (n = 600), in 2004 to assess dengue seroprevalence. Recent dengue infection was detected in 2% (95% confidence interval [CI] 0.5%-3.5%) and 7.3% (95% CI 4.3%-10.3%) of residents in Brownsville and Matamoros, respectively. Past infection was detected in 40% (95% CI 34%-45%) of Brownsville residents and 78% (95% CI 74%-83%) of Matamoros residents. For recent infection, only weekly family income <or=$100 was a significant predictor (adjusted odds ratio 3.2, 95% CI 1.3-8.0). Risk factors that predicted past dengue infection were presence of larval habitat, absence of air-conditioning and street drainage, and weekly family income <or=$100. Mosquito larvae were present in 30% of households in both cities. Our results show that dengue fever is endemic in this area of the southern Texas-Mexico border.

Figures

Figure
Figure
Map of Brownsville, Texas, and Matamoros, Mexico, contiguous cities on the US–Mexico border. Source: US Geological Survey; available from http://borderhealth.cr.usgs.gov/staticmaplib.html

References

    1. Monath TP. Dengue: the risk to developed and developing countries. Proc Natl Acad Sci U S A. 1994;91:2395–400. 10.1073/pnas.91.7.2395
    1. Gubler DJ. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev. 1998;11:480–96.
    1. World Health Organization. Dengue haemorrhagic fever: diagnosis, treatment, prevention, and control. Geneva: The Organization; 1997.
    1. Gibbons RV, Vaughn DW. Dengue: an escalating problem. BMJ. 2002;324:1563–6. 10.1136/bmj.324.7353.1563
    1. Reiter P. Climate change and mosquito-borne disease. Environ Health Perspect. 2001;109(Suppl 1):141–61. 10.2307/3434853
    1. Hafkin B, Kaplan JE, Reed C, Elliott LB, Fontaine R, Sather GE, et al. Reintroduction of dengue fever into the continental United States. I. Dengue surveillance in Texas, 1980. Am J Trop Med Hyg. 1982;31:1222–8.
    1. Centers for Disease Control and Prevention. Underdiagnosis of dengue—Laredo, Texas, 1999. MMWR Morb Mortal Wkly Rep. 2001;50:57–9.
    1. Rawlings JA, Hendricks KA, Burgess CR, Campman RM, Clark GG, Tabony LJ, et al. Dengue surveillance in Texas, 1995. Am J Trop Med Hyg. 1998;59:95–9.
    1. Centers for Disease Control and Prevention. Imported and indigenous dengue fever—United States, 1986. MMWR Morb Mortal Wkly Rep. 1987;36:551–4.
    1. Centers for Disease Control and Prevention. Dengue fever at the U.S.-Mexico border, 1995–1996. MMWR Morb Mortal Wkly Rep. 1996;45:841–4.
    1. Intergovernmental Panel on Climate Change (IPCC). Climate change 2001: impacts, adaptation and vulnerability. Technical summary. Geneva: IPCC Secretariat; 2001.
    1. US National Research Council, Committee on Climate Ecosystems Infectious Disease and Human Health. Under the weather: climate, ecosystems, and infectious disease. Washington: National Academy Press; 2001.
    1. Gubler DJ, Reiter P, Ebi KL, Yap W, Nasci R, Patz JA. Climate variability and change in the United States: potential impacts on vector- and rodent-borne diseases. Environ Health Perspect. 2001;109(Suppl 2):223–33. 10.2307/3435012
    1. Reiter P, Lathrop S, Bunning M, Biggerstaff B, Singer D, Tiwari T, et al. Texas lifestyle limits transmission of dengue virus. Emerg Infect Dis. 2003;9:86–9.
    1. US Census Bureau. Census 2000 summary file 1, 2000. [cited 2004 Sep 9]. Available from
    1. Instituto Nacional de Estadística Geografía e Informática (INEGI). XII Censo general de población y vivienda, 2000. [cited 2004 Sep 9]. Available from
    1. Miagostovich MP, Nogueira RM, dos Santos FB, Schatzmayr HG, Araujo ES, Vorndam V. Evaluation of an IgG enzyme-linked immunosorbent assay for dengue diagnosis. J Clin Virol. 1999;14:183–9. 10.1016/S1386-6532(99)00059-1
    1. World Health Organization (WHO). Dengue haemorrhagic fever: diagnosis, treatment, and control. Albany (NY): WHO Publications Center USA; 1986.
    1. Russell PK, Nisalak A, Sukhavachana P, Vivona S. A plaque reduction test for dengue virus neutralizing antibodies. J Immunol. 1967;99:285–90.
    1. Service MW. Mosquito ecology: field sampling methods. London: Elsevier Applied Science; 1993.
    1. Innis BL, Nisalak A, Nimmannitya S, Kusalerdchariya S, Chongswasdi V, Suntayakorn S, et al. An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate. Am J Trop Med Hyg. 1989;40:418–27.
    1. Ruechusatsawat K, Morita K, Tanaka M, Vongcheree S, Rojanasuphot S, Warachit P, et al. Daily observation of antibody levels among dengue patients detected by enzyme-linked immunosorbent assay (ELISA). Jpn J Trop Med Hyg. 1994;22:9–12.
    1. Chatterjee S, Hadi AS, Price B. Regression analysis by example. New York: Wiley; 2000.
    1. Secretariat of Health. Mexico. Boletin Epidemiologia. 2005. [cited 26 Nov 2005]. Available from
    1. Siqueira JB, Martelli CM, Maciel IJ, Oliveira RM, Ribeiro MG, Amorim FP, et al. Household survey of dengue infection in central Brazil: spatial point pattern analysis and risk factors assessment. Am J Trop Med Hyg. 2004;71:646–51.
    1. Thai KT, Binh TQ, Giao PT, Phuong HL, Hung le Q, Van Nam N, et al. Seroprevalence of dengue antibodies, annual incidence and risk factors among children in southern Vietnam. Trop Med Int Health. 2005;10:379–86. 10.1111/j.1365-3156.2005.01388.x
    1. Tuntaprasart W, Barbazan P, Nitatpattana N, Rongsriyam Y, Yoksan S, Gonzalez JP. Seroepidemiological survey among schoolchildren during the 2000–2001 dengue outbreak of Ratchaburi Province, Thailand. Southeast Asian J Trop Med Public Health. 2003;34:564–8.
    1. Navarrete-Espinosa J, Acevedo-Vales JA, Huerta-Hernandez E, Torres-Barranca J, Gavaldon-Rosas DG. [Prevalence of dengue and leptospira antibodies in the state of Veracruz, Mexico] [in Spanish]. Salud Publica Mex. 2006;48:220–8. 10.1590/S0036-36342006000300006
    1. Balmaseda A, Hammond SN, Tellez Y, Imhoff L, Rodriguez Y, Saborio SI, et al. High seroprevalence of antibodies against dengue virus in a prospective study of schoolchildren in Managua, Nicaragua. Trop Med Int Health. 2006;11:935–42. 10.1111/j.1365-3156.2006.01641.x
    1. Rice L. Dengue fever: preliminary report of an epidemic at Galveston. Tex State J Med. 1922;189:217–8.
    1. Ehrenkranz NJ, Ventura AK, Cuadrado RR, Pond WL, Porter JE. Pandemic dengue in Caribbean countries and the southern United States—past, present and potential problems. N Engl J Med. 1971;285:1460–9.
    1. Briseño-García B, Gόmez-Dantés H, Argott-Ramírez E, Montesano R, Vázquez-Martínez AL, Ibáñez-Bernal S, et al. Potential risk of dengue hemorrhagic fever: the isolation of serotype dengue 3 in Mexico. Emerg Infect Dis. 1996;2:133–5. 10.3201/eid0202.960210
    1. Navarrete-Espinosa J, Gómez-Dantés H, Germán Celis-Quintal J, Vázquez-Martínez JL. Clinical profile of dengue hemorrhagic fever cases in Mexico. Salud Publica Mex. 2005;47:193–200. 10.1590/S0036-36342005000300002
    1. Halstead SB. Observations related to pathogensis of dengue hemorrhagic fever. VI. Hypotheses and discussion. Yale J Biol Med. 1970;42:350–62.
    1. Halstead SB, Rojanasuphot S, Sangkawibha N. Original antigenic sin in dengue. Am J Trop Med Hyg. 1983;32:154–6.
    1. Rosen L. The Emperor's New Clothes revisited, or reflections on the pathogenesis of dengue hemorrhagic fever. Am J Trop Med Hyg. 1977;26:337–43.
    1. Murgue B, Deparis X, Chungue E, Cassar O, Roche C. Dengue: an evaluation of dengue severity in French Polynesia based on an analysis of 403 laboratory-confirmed cases. Trop Med Int Health. 1999;4:765–73. 10.1046/j.1365-3156.1999.00478.x

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren